Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Mark R Hanudel"'
Autor:
Ornatcha Sirimongkolchaiyakul, Katherine Wesseling‐Perry, Barbara Gales, Daniela Markovic, David Elashoff, Georgina Ramos, Renata C Pereira, Mark R Hanudel, Isidro B Salusky
Publikováno v:
JBMR Plus, Vol 6, Iss 4, Pp n/a-n/a (2022)
ABSTRACT Congenital diseases of the kidney and urinary tract (CAKUT) and glomerulonephritis are the main causes of chronic kidney disease (CKD) in children. Although renal osteodystrophy (ROD) and indices of mineral metabolism have been characterized
Externí odkaz:
https://doaj.org/article/9db22676191148cc8a30b313ac705fc6
Autor:
Mark R Hanudel, Matthew S Zinter, Lucia Chen, Kinisha Gala, Michelle Lim, Mona Guglielmo, Tanaya Deshmukh, Sitaram Vangala, Michael Matthay, Anil Sapru
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222065 (2019)
Acute respiratory distress syndrome (ARDS) has high rates of mortality and multisystem morbidity. Pre-clinical data suggest that fibroblast growth factor 23 (FGF23) may contribute to pulmonary pathology, and FGF23 is associated with mortality and mor
Externí odkaz:
https://doaj.org/article/70fcdfd418a147008c9cc3d07a09df78
Autor:
Mark R. Hanudel
Publikováno v:
Kidney International.
Autor:
Shilpa Sharma, Mark R. Hanudel, Joachim H. Ix, Isidro B. Salusky, Tomas Ganz, Kim-Lien Nguyen
Publikováno v:
Kidney International Reports, Vol 5, Iss 7, Pp 1119-1120 (2020)
Externí odkaz:
https://doaj.org/article/973e4a4de6714a54bc95c5ca1976cc29
Autor:
Matt S. Zinter, Mona Guglielmo, Sitaram Vangala, Lucia Chen, Michelle Lim, Kayley Man Yee Wong, Mustafa F. Alkhouli, Kinisha Gala, Anil Sapru, Andreas Schwingshackl, Michael A. Matthay, Leanna Huard, Anoopindar K. Bhalla, Mark R. Hanudel
Publikováno v:
Critical care medicine, vol 50, iss 5
ObjectivesSoluble receptor for advanced glycation end products is a known plasma marker of alveolar epithelial injury. However, RAGE is also expressed on cell types beyond the lung, and its activation leads to up-regulation of pro-inflammatory mediat
Autor:
Shilpa Sharma, Nisha R. Patel, Mark R. Hanudel, Joachim H. Ix, Isidro B. Salusky, Kim-Lien Nguyen
Publikováno v:
Pediatric Nephrology.
Publikováno v:
Kidney International. 100:79-89
Vadadustat is an investigational hypoxia-inducible factor prolyl hydroxylase inhibitor that increases endogenous erythropoietin production and has been shown to decrease hepcidin levels, ameliorate iron restriction, and increase hemoglobin concentrat
Autor:
Victoria Gabayan, Maxime Rappaport, Brian Czaya, Kristine Chua, Grace Jung, Elizabeta Nemeth, Bo Qiao, Mark R. Hanudel, Shweta S. Namjoshi, Tomas Ganz, Shirley Wong
Publikováno v:
Kidney international, vol 101, iss 4
Ferric citrate is approved as an iron replacement product in patients with non-dialysis chronic kidney disease and iron deficiency anemia. Ferric citrate-delivered iron is enterally absorbed, but the specific mechanisms involved have not been evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20148d81682033a2c1b2aea0315ff032
https://escholarship.org/uc/item/38z3d48w
https://escholarship.org/uc/item/38z3d48w
Autor:
Pien Rawee, Daan Kremer, Ilja M. Nolte, Henri G. D. Leuvenink, Daan J. Touw, Martin H. De Borst, Stephan J. L. Bakker, Mark R. Hanudel, Michele F. Eisenga
Publikováno v:
International Journal of Molecular Sciences. 24:5315
Heavy metals are common in our environment, and all individuals are exposed to them to some extent. These toxic metals have several harmful effects on the body, including the kidney, which is a very sensitive organ. Indeed, heavy metal exposure has b
Autor:
Mark J. Koury, Rajiv Agarwal, Glenn M. Chertow, Kai‐Uwe Eckardt, Steven Fishbane, Tomas Ganz, Volker H. Haase, Mark R. Hanudel, Patrick S. Parfrey, Pablo E. Pergola, Prabir Roy‐Chaudhury, James A. Tumlin, Robert Anders, Youssef M. K. Farag, Wenli Luo, Todd Minga, Christine Solinsky, Dennis L. Vargo, Wolfgang C. Winkelmayer
Patients with chronic kidney disease (CKD) develop anemia largely because of inappropriately low erythropoietin (EPO) production and insufficient iron available to erythroid precursors. In four phase 3, randomized, open-label, clinical trials in dial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95fbda48105c9cc626a3af0a7bab6c62
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-479451
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-479451